Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
3.748 of 5 stars
$17.96-0.7%N/AN/AModerate Buy$35.71
Ultragenyx Pharmaceutical (RARE)
2.7051 of 5 stars
$16.694.9%N/AN/AHold$29.79
Sarepta Therapeutics (SRPT)
3.4856 of 5 stars
$14.76-2.5%N/AN/AHold$23.67
Pfizer (PFE)
2.8229 of 5 stars
$28.43-1.5%6.05%40.62Hold$30.32
Exelixis (EXEL)
2.2563 of 5 stars
$68.472.0%N/A20.49Hold$58.62
Moderna (MRNA)
1.4019 of 5 stars
$206.59-4.0%N/AN/AHold$120.25
United Therapeutics (UTHR)
4.6971 of 5 stars
$582.46-0.9%N/A21.98Moderate Buy$676.40
Biogen (BIIB)
3.0409 of 5 stars
$250.95-0.3%N/A107.11Moderate Buy$254.41
Sanofi (SNY)
4.0921 of 5 stars
$47.60-1.6%3.70%23.58Hold$53.00
Eli Lilly and Company (LLY)
3.8191 of 5 stars
$1,412.35-1.3%0.49%45.81Moderate Buy$1,422.00

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines